Annual ROE
-21.25%
+102.41%+82.82%
31 December 2023
Summary:
Sunshine Biopharma annual return on equity is currently -21.25%, with the most recent change of +102.41% (+82.82%) on 31 December 2023. During the last 3 years, it has fallen by -312.83% (-107.29%). SBFMW annual ROE is now -100.07% below its all-time high of 32.31 thousand%, reached on 31 December 2013.SBFMW ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-17.88%
-1.79%-11.12%
30 September 2024
Summary:
Sunshine Biopharma quarterly return on equity is currently -17.88%, with the most recent change of -1.79% (-11.12%) on 30 September 2024. Over the past year, it has increased by +106.44% (+85.62%). SBFMW quarterly ROE is now -100.76% below its all-time high of 2362.73%, reached on 31 December 2021.SBFMW Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.8% | +85.6% |
| 3 y3 years | -107.3% | -100.9% |
| 5 y5 years | -100.5% | -105.1% |
SBFMW ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -107.3% | +99.6% | -100.8% | +95.8% |
| 5 y | 5 years | -100.5% | +99.6% | -100.8% | +95.8% |
| alltime | all time | -100.1% | +99.6% | -100.8% | +99.8% |
Sunshine Biopharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -17.88%(+11.1%) |
| June 2024 | - | -16.09%(-10.4%) |
| Mar 2024 | - | -17.95%(-14.6%) |
| Dec 2023 | -21.25%(-82.8%) | -21.03%(-83.1%) |
| Sept 2023 | - | -124.32%(+17.9%) |
| June 2023 | - | -105.49%(+19.5%) |
| Mar 2023 | - | -88.25%(-3.3%) |
| Dec 2022 | -123.66%(-97.9%) | -91.27%(+1282.9%) |
| Sept 2022 | - | -6.60%(-88.3%) |
| June 2022 | - | -56.49%(-86.8%) |
| Mar 2022 | - | -428.44%(-118.1%) |
| Dec 2021 | -5875.62%(-2115.1%) | 2362.73%(+20.8%) |
| Sept 2021 | - | 1955.86%(+29.0%) |
| June 2021 | - | 1516.25%(+41.2%) |
| Mar 2021 | - | 1074.05%(+202.1%) |
| Dec 2020 | 291.58%(+29.1%) | 355.57%(+26.9%) |
| Sept 2020 | - | 280.14%(+32.4%) |
| June 2020 | - | 211.52%(+2.3%) |
| Mar 2020 | - | 206.72%(-22.0%) |
| Dec 2019 | 225.77%(-94.2%) | 264.98%(-24.5%) |
| Sept 2019 | - | 350.87%(-57.8%) |
| June 2019 | - | 831.30%(-50.5%) |
| Mar 2019 | - | 1677.83%(+53.3%) |
| Dec 2018 | 3867.33%(+2031.6%) | 1094.63%(+76.1%) |
| Sept 2018 | - | 621.66%(+108.7%) |
| June 2018 | - | 297.89%(+37.1%) |
| Mar 2018 | - | 217.23%(-5.8%) |
| Dec 2017 | 181.43%(-89.1%) | 230.58%(-57.5%) |
| Sept 2017 | - | 542.22%(-69.4%) |
| June 2017 | - | 1774.61%(-8.8%) |
| Mar 2017 | - | 1945.28%(+10.0%) |
| Dec 2016 | 1667.47% | 1768.64%(+72.5%) |
| Sept 2016 | - | 1025.29%(+187.1%) |
| June 2016 | - | 357.11%(-17.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | 431.63%(-7.4%) |
| Dec 2015 | 276.85%(-44.5%) | 466.36%(+5.2%) |
| Sept 2015 | - | 443.43%(-9.9%) |
| June 2015 | - | 491.97%(-12.2%) |
| Mar 2015 | - | 560.50%(-19.2%) |
| Dec 2014 | 499.05%(-98.5%) | 693.64%(-44.2%) |
| Sept 2014 | - | 1243.34%(-41.5%) |
| June 2014 | - | 2124.59%(-125.6%) |
| Mar 2014 | - | -8287.97%(+251.5%) |
| Dec 2013 | 32.31 K%(-3314.7%) | -2357.82%(+48.0%) |
| Sept 2013 | - | -1593.63%(+28.2%) |
| June 2013 | - | -1243.40%(-7.3%) |
| Mar 2013 | - | -1341.51%(+121.2%) |
| Dec 2012 | -1005.24%(+86.2%) | -606.55%(-15.0%) |
| Sept 2012 | - | -713.78%(+31.8%) |
| June 2012 | - | -541.63%(+31.6%) |
| Mar 2012 | - | -411.71%(+15.9%) |
| Dec 2011 | -539.99%(+97.2%) | -355.15%(+13.9%) |
| Sept 2011 | - | -311.73%(-142.4%) |
| June 2011 | - | 735.00%(-260.8%) |
| Mar 2011 | - | -457.17%(-37.6%) |
| Dec 2010 | -273.87%(-255.9%) | -732.79%(+47.9%) |
| Sept 2010 | - | -495.61%(-88.7%) |
| June 2010 | - | -4370.67%(+78.5%) |
| Mar 2010 | - | -2448.63%(-60.1%) |
| Oct 2009 | - | -6135.15%(-8012.2%) |
| July 2009 | - | 77.54%(-7.8%) |
| Apr 2009 | - | 84.13%(-43.2%) |
| Jan 2009 | - | 148.11%(-33.7%) |
| Oct 2008 | - | 223.40%(-59.0%) |
| July 2008 | 175.64%(-279.3%) | 544.73%(-63.4%) |
| Apr 2008 | - | 1489.65%(-568.3%) |
| Jan 2008 | - | -318.12%(+66.8%) |
| Oct 2007 | - | -190.75% |
| July 2007 | -97.96% | - |
FAQ
- What is Sunshine Biopharma annual return on equity?
- What is the all time high annual ROE for Sunshine Biopharma?
- What is Sunshine Biopharma annual ROE year-on-year change?
- What is Sunshine Biopharma quarterly return on equity?
- What is the all time high quarterly ROE for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly ROE year-on-year change?
What is Sunshine Biopharma annual return on equity?
The current annual ROE of SBFMW is -21.25%
What is the all time high annual ROE for Sunshine Biopharma?
Sunshine Biopharma all-time high annual return on equity is 32.31 K%
What is Sunshine Biopharma annual ROE year-on-year change?
Over the past year, SBFMW annual return on equity has changed by +102.41% (+82.82%)
What is Sunshine Biopharma quarterly return on equity?
The current quarterly ROE of SBFMW is -17.88%
What is the all time high quarterly ROE for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly return on equity is 2362.73%
What is Sunshine Biopharma quarterly ROE year-on-year change?
Over the past year, SBFMW quarterly return on equity has changed by +106.44% (+85.62%)